A. Calazans

发表

Genotypic Analysis of the gp41 HR1 Region From HIV-1 isolates From Enfuvirtide-Treated and Untreated Patients

A. Tanuri, C. Abreu, J. Couto-Fernandez, 2011, Journal of acquired immune deficiency syndromes.

Synthesis of Pseudopeptides Derived from (R,R)-Tartaric Acid as Potential Inhibitors of HIV-Protease

A. Tanuri, J. Williamson, O. Antunes, 2006 .

Low accumulation of L90M in protease from subtype F HIV-1 with resistance to protease inhibitors is caused by the L89M polymorphism.

A. Tanuri, J. A. Guimarães, O. Antunes, 2005, The Journal of infectious diseases.

Molecular dynamics analysis of HIV-1 matrix protein: clarifying differences between crystallographic and solution structures.

A. Tanuri, J. A. Guimarães, H. Verli, 2007, Journal of molecular graphics & modelling.

A DNA inducing VLP vaccine designed for HIV and tested in mice

R. Lindsay, C. Boggiano, A. Calazans, 2017, PloS one.

In Vitro Hypersusceptibility of Human Immunodeficiency Virus Type 1 Subtype C Protease to Lopinavir

M. Soares, A. Tanuri, S. Cassol, 2003, Antimicrobial Agents and Chemotherapy.

Genotypic and Phenotypic Evidence of Different Drug-Resistance Mutation Patterns between B and Non-B Subtype Isolates of Human Immunodeficiency Virus Type 1 found in Brazilian Patients Failing HAART

K. Hertogs, B. Larder, A. Tanuri, 2004, Virus Genes.

Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART.

K. Hertogs, B. Larder, A. Tanuri, 2000, Virology.

Crystallization of a non-B and a B mutant HIV protease.

A. Tanuri, I. Polikarpov, O. Antunes, 2004, Acta crystallographica. Section D, Biological crystallography.

Synthesis and anti-HIV activity of new C2 symmetric derivatives designed as HIV-1 protease inhibitors.

A. Tanuri, O. Antunes, R. Brindeiro, 2003, Farmaco.